News

October 15, 2018

Organs May Actively Fight Autoimmune Diseases, SLE Study Suggests

News

Organs affected by autoimmune disease might be able to suppress T-cell function in a manner that is similar to tumors, actively preventing them from causing damage, a study in ... Read more

October 12, 2018

Xencor’s Candidate Antibody Therapy for Lupus Shows Positive Results in Phase 2 Study

News

Xencor announced top-line results from its Phase 2 clinical trial testing the candidate antibody therapy XmAb5871 for the treatment of systemic lupus erythematosus (SLE). The antibody seems to help control or reduce lupus ... Read more

October 10, 2018October 10, 2018

Childhood SLE Has Major Impact in Adulthood, Dutch Study Shows

News

People with childhood-onset systemic lupus erythematosus (cSLE) develop significant disease-associated damage early in life and have lower quality of life in their adulthood, without achieving medication-free remission, according to ... Read more

October 8, 2018

Aurinia Completes Enrollment for Phase 3 Trial Testing Voclosporin to Treat Lupus Nephritis

News

Aurinia Pharmaceuticals has completed patient enrollment for its Phase 3 trial that will assess the potential of voclosporin as an add-on to standard treatment regimens in patients with lupus ... Read more

October 5, 2018

Black, Hispanic SLE Patients in US at Higher Stroke Risk Than Whites, Study Reports

News

Rates of both ischemic and hemorrhagic strokes in systemic lupus erythematosus (SLE) are affected by the racial and ethnic background of patients, a U.S. study reports, which may help ... Read more

October 3, 2018October 3, 2018

Diagnostic Tests for SLE Should Include New Variants Found in African Patients, Study Suggests

News

Black Africans often have distinct variants of systemic lupus erythematosus compared to white patients, but conventional diagnostic tests can’t detect these variants, say researchers from Scotland’s University of Edinburgh and collaborators ... Read more

October 1, 2018

Ustekinumab as Add-on Therapy Was Seen to Benefit SLE Patients in Phase 2 Trial

News

Ustekinumab as an add-on to standard of care was seen to significantly increase the number of systemic lupus erythematosus (SLE) patients with a reduction in disease activity compared to standard ... Read more

September 28, 2018

High SLE Disease Activity Over Time Warrants New Treatments, Study Asserts

News

The activity of systemic lupus erythematosus (SLE) is persistently high in a large proportion of patients, despite high rates of steroids and immunosuppressants use, according to a five-year study. The ... Read more

September 26, 2018September 26, 2018

Mercy College Researchers Get $600K Grant to Study Care, Research Gaps Among Young Lupus Patients

News

To help address disparities in the research and care of adolescents with lupus, the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) has awarded Mercy College a three-year, $600,000 ... Read more

September 24, 2018

Soliris Seen as Effective at Treating Lupus Nephritis Patients with TMA, Rare Disease of Small Vessels

News

Patients with lupus nephritis — a lupus-associated type of kidney inflammation — can sometimes develop a rare immune disorder, called thrombotic microangiopathy, as a consequence of excessive activation of the complement system. ... Read more

This is a short description about myself and what this site is about. I hope you enjoy being here!

News

Organs May Actively Fight Autoimmune Diseases, SLE Study Suggests

Xencor’s Candidate Antibody Therapy for Lupus Shows Positive Results in Phase 2 Study

Childhood SLE Has Major Impact in Adulthood, Dutch Study Shows

Aurinia Completes Enrollment for Phase 3 Trial Testing Voclosporin to Treat Lupus Nephritis

Black, Hispanic SLE Patients in US at Higher Stroke Risk Than Whites, Study Reports

Diagnostic Tests for SLE Should Include New Variants Found in African Patients, Study Suggests

Ustekinumab as Add-on Therapy Was Seen to Benefit SLE Patients in Phase 2 Trial

High SLE Disease Activity Over Time Warrants New Treatments, Study Asserts

Mercy College Researchers Get $600K Grant to Study Care, Research Gaps Among Young Lupus Patients

Soliris Seen as Effective at Treating Lupus Nephritis Patients with TMA, Rare Disease of Small Vessels

Pin It on Pinterest